Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**l-arginine + omega-3 fatty acids** is a combination dietary supplement comprised of the amino acid l-arginine and omega-3 polyunsaturated fatty acids, most commonly EPA and DHA. l-arginine is a precursor to nitric oxide, leading to vasodilation and improved blood flow. Omega-3 fatty acids exhibit anti-inflammatory effects and cardiovascular protection by inhibiting pro-inflammatory cytokines and lowering triglycerides. This combination has been studied for its role in enhancing wound healing, reducing surgical site infections, improving cardiovascular outcomes, and supporting immune modulation, with evidence suggesting synergistic effects beyond either component alone[4][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-arginine + omega-3 fatty acids.